Skip to main content
Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Sodium-dependent glucose transporter 2 inhibitor alleviates renal lipid deposition and improves renal oxygenation levels in newly diagnosed type 2 diabetes mellitus patients: a randomized controlled trial

Fig. 5

Correlation between the improvement of renal oxygenation level and the change of renal fat deposition in newly diagnosed type 2 diabetic patients after treatment with Canagliflozin. A, B. Correlation analysis of renal cortex R2* value and renal fat fraction (FF) before and after treatment C, D Correlation analysis of renal medulla R2* value and renal FF before and after treatment E, F. Correlation analysis of renal cortex and medulla â–³R2* value and â–³FF after treatment

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us